1026409-70-0

Upstream product

• 131341-62-3 (R)-(-)-2-<3-(benzyloxy)-5-fluorophenyl>-2-hydroxybutyric acid 
• 74-88-4 methyl iodide 

Downstream Products

• 153441-19-1 (R)-(-)-1-<3-(benzyloxy)-5-fluorophenyl>-1-(thiazol-2-yl)propyl methyl 4ther 
• 153441-17-9 (R)-(+)-2-<3-(benzyloxy)-5-fluorophenyl>-2-methoxybutanal 
• 153441-21-5 (R)-(-)-1-(3-hydroxy-5-fluorophenyl)-1-(thiazol-2-yl)propyl methyl ether 
• 153441-15-7 (R)-(-)-2-<3-(benzyloxy)-5-fluorophenyl>-2-methoxybutanol 
• 153441-34-0 (R)-(+)-methyl 2-(3-hydroxy-5-fluorophenyl)-2-methoxybutyrate 

Relevant academic research and scientific papers

Conformational analysis of 5-lipoxygenase inhibitors: Role of the substituents in chiral recognition and on the active conformations of the (methoxyalkyl)thiazole and methoxytetrahydropyran series

The investigation of the SAR of 5-lipoxygenase (5-LO) inhibition of a series of racemic (methoxyalkyl)thiazoles, exemplified by compound 7 (ZM- 211965), has led to other active, racemic derivatives in which the thiazole moiety has been replaced by an este